The effect of patient delay and tretment delay on survival in ptients with lung cancer is still under debate.The aim of this study is to analyse this two delays and study their impact on survival


We conducted a retrospective cohort study of patients diagnosed with lung cancer between 2012 and 2021. Patient delay was defined as the time from tne onset of symtoms to first consultation; treatment delay was defined as the time from the diagnosis to the first treatment.

Results: A total of 182 patients were icluded with a Median age of 64 years and 93% male . 17patients were never smokers .Assessment of general condition at diagnosis using the WHO PS score revealed PS <2 in 111 patients (69, 8%).the most frequent histologic types were adenocarcinoma in 53% and squamous cell carcinoma in (32%). The mean patient delay was 110 days; the mean treatment delay was 48 days. A higher survival was associated with a patient delay<100 days (p=0.04) and a treatment delay < 30 days(p=0.04).

Coclusion: our study shows that shortening the patient and treatment delay could improve patient survival.